Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st
Aclarion (Nasdaq: ACON), a healthcare technology company specializing in chronic low back pain diagnosis through biomarkers and AI algorithms, has announced its participation in the upcoming Virtual Investor Summit Microcap Event on November 21st, 2024. The company will deliver a presentation from 3:30 PM to 4:00 PM ET and will be available for one-on-one meetings throughout the day.
The event will showcase 40 micro-cap companies with catalysts and strong market performance. The presentation will be accessible via webcast, and qualified investors can register for complimentary access to participate in live Q&A sessions.
Aclarion (Nasdaq: ACON), un'azienda tecnologica nel settore sanitario specializzata nella diagnosi del dolore cronico alla schiena tramite biomarcatori e algoritmi di intelligenza artificiale, ha annunciato la sua partecipazione al prossimo Virtual Investor Summit Microcap Event del 21 novembre 2024. L'azienda presenterà dalle 15:30 alle 16:00 ET e sarà disponibile per incontri individuali durante tutta la giornata.
L'evento presenterà 40 aziende micro-cap con catalizzatori e buone performance di mercato. La presentazione sarà accessibile tramite webcast e gli investitori qualificati possono registrarsi per avere accesso gratuito per partecipare alle sessioni di domande e risposte dal vivo.
Aclarion (Nasdaq: ACON), una empresa de tecnología en el sector salud especializada en el diagnóstico del dolor lumbar crónico a través de biomarcadores y algoritmos de inteligencia artificial, ha anunciado su participación en el próximo Virtual Investor Summit Microcap Event el 21 de noviembre de 2024. La empresa realizará una presentación de 3:30 PM a 4:00 PM ET y estará disponible para reuniones individuales a lo largo del día.
El evento exhibirá 40 empresas micro-cap con catalizadores y un sólido desempeño en el mercado. La presentación estará disponible a través de un webcast, y los inversores calificados pueden registrarse para obtener acceso gratuito y participar en sesiones de preguntas y respuestas en vivo.
Aclarion (Nasdaq: ACON)은 바이오마커 및 AI 알고리즘을 통해 만성 요통 진단을 전문으로 하는 헬스케어 기술 회사로, 2024년 11월 21일에 열리는 Virtual Investor Summit Microcap Event에 참여한다고 발표했습니다. 회사는 동부 표준시 기준으로 오후 3시 30분부터 4시까지 발표를 하며, 하루 종일 개별 미팅을 진행할 예정입니다.
이 행사에서는 촉매가 있는 40개의 마이크로 캡 기업과 강력한 시장 성과를 보여줄 예정입니다. 발표는 웹캐스트를 통해 제공되며, 자격을 갖춘 투자자는 무료로 등록하여 실시간 Q&A 세션에 참여할 수 있습니다.
Aclarion (Nasdaq: ACON), une entreprise de technologie de la santé spécialisée dans le diagnostic de la douleur lombaire chronique à travers des biomarqueurs et des algorithmes d'IA, a annoncé sa participation au prochain Virtual Investor Summit Microcap Event le 21 novembre 2024. L'entreprise présentera de 15h30 à 16h00 ET et sera disponible pour des réunions individuelles tout au long de la journée.
L'événement mettra en avant 40 entreprises micro-cap avec des catalyseurs et des performances solides sur le marché. La présentation sera accessible via un webinaire et les investisseurs qualifiés peuvent s'inscrire pour un accès gratuit afin de participer à des sessions de questions-réponses en direct.
Aclarion (Nasdaq: ACON), ein Unternehmen für Gesundheitstechnologie, das sich auf die Diagnose von chronischen unteren Rückenschmerzen durch Biomarker und KI-Algorithmen spezialisiert hat, hat seine Teilnahme am bevorstehenden Virtual Investor Summit Microcap Event am 21. November 2024 angekündigt. Das Unternehmen wird von 15:30 bis 16:00 Uhr ET eine Präsentation halten und steht den ganzen Tag für Einzelgespräche zur Verfügung.
Die Veranstaltung wird 40 Mikro-Kapitalunternehmen mit Katalysatoren und starker Marktleistung vorstellen. Die Präsentation wird über ein Webcast zugänglich sein, und qualifizierte Investoren können sich für den kostenlosen Zugang registrieren, um an Live-Q&A-Sitzungen teilzunehmen.
- None.
- None.
BROOMFIELD, CO / ACCESSWIRE / November 14, 2024 / Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq:ACON)(Nasdaq:ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced its participation at the upcoming Virtual Investor Summit Microcap Event on November 21st. The Company will be available for 1-on-1 meetings throughout the day in addition to its formal presentation.
Event: Q4 Investor Summit
Presentation date and time: November 21, 2024, 3:30pm - 4:00pm ET
Location: https://www.webcaster4.com/Webcast/Page/3075/51667
The theme is 40 micro-cap companies with a catalyst and/or strong performance in the current market.
Take a deep dive with the best Investors in MicroCap
Live Q & A
Complimentary to Qualified Investors. Please REGISTER HERE.
About the Investor Summit
The Investor Summit is an exclusive, independent conference dedicated to connecting small cap and microcap companies with qualified investors. Founded in 2015.
About Aclarion, Inc.
Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy ("MRS"), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies. For more information, please visit www.aclarion.com.
Investor Contacts:
Kirin M. Smith
PCG Advisory, Inc.
646.823.8656
ksmith@pcgadvisory.com
Media Contacts:
Jodi Lamberti
SPRIG Consulting
612.812.7477
jodi@sprigconsulting.com
SOURCE: Aclarion, Inc.
View the original press release on accesswire.com
FAQ
When is Aclarion (ACON) presenting at the Virtual Investor Summit Microcap Event?
How can investors attend Aclarion's (ACON) Virtual Investor Summit presentation?
What will be featured at the 2024 Virtual Investor Summit Microcap Event where Aclarion (ACON) is presenting?
What type of technology does Aclarion (ACON) specialize in?
